nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Case of Hypercalcemia from PTHrP-Producing Fibromyxoid Sarcoma Responsive to Glucocorticoid Therapy
|
Niu, Isabella |
|
|
113 |
2 |
p. 246-253 |
artikel |
2 |
Alcohol Consumption and Measures of Sarcopenic Muscle Risk: Cross-Sectional and Prospective Associations Within the UK Biobank Study
|
Skinner, Jane |
|
|
113 |
2 |
p. 143-156 |
artikel |
3 |
Association of PFN1 Gene Polymorphisms with Bone Mineral Density, Bone Turnover Markers, and Osteoporotic Fractures in Chinese Population
|
Wu, Yinghao |
|
|
113 |
2 |
p. 207-215 |
artikel |
4 |
Bisphosphonate FYB-931 Prevents High Phosphate-Induced Vascular Calcification in Rat Aortic Rings by Altering the Dynamics of the Transformation of Calciprotein Particles
|
Kawakami, Kazuki |
|
|
113 |
2 |
p. 216-228 |
artikel |
5 |
Bone Mineral Density in Neurofibromatosis Type 1: A Systematic Review and Meta-Analysis
|
Charoenngam, Nipith |
|
|
113 |
2 |
p. 166-174 |
artikel |
6 |
Comment on One-Year Romosozumab Treatment Followed by One-Year Denosumab Treatment for Osteoporosis in Patients on Hemodialysis: An Observational Study
|
Ogata, Masatomo |
|
|
113 |
2 |
p. 254-255 |
artikel |
7 |
Medical Care Use Among Patients with Monogenic Osteoporosis Due to Rare Variants in LRP5, PLS3, or WNT1
|
Verdonk, S. J. E. |
|
|
113 |
2 |
p. 186-194 |
artikel |
8 |
Nonresponder Considerations for Romosozumab Treatment
|
Tominaga, Ayako |
|
|
113 |
2 |
p. 157-165 |
artikel |
9 |
Physical Functioning in Patients with a Recent Fracture: The “Can Do, Do Do” Framework Applied to Explore Physical Capacity, Physical Activity and Fall Risk Factors
|
Schene, M. R. |
|
|
113 |
2 |
p. 195-206 |
artikel |
10 |
Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors and the Risk of Fracture: A Systematic Review and Meta-analysis of Randomized Controlled Trials
|
Lv, Fang |
|
|
113 |
2 |
p. 175-185 |
artikel |
11 |
The Contribution of Perilacunar Composition and Mechanical Properties to Whole-Bone Mechanical Outcomes in Streptozotocin-Induced Diabetes
|
Bolger, Morgan W. |
|
|
113 |
2 |
p. 229-245 |
artikel |